文献速递神经介入CTMRDSA

脑膜中动脉栓塞治疗慢性硬膜下血肿:时机与基线血肿体积的作用

Middle meningeal artery embolization for chronic subdural hematoma: the role of timing and baseline hematoma volume.
PubMed 文献 · Neuroradiology · 2026-06-30

本研究纳入135例接受脑膜中动脉栓塞的慢性硬膜下血肿患者,按术前血肿体积四分位分层并比较术前、术后及单独栓塞三种治疗时机。入院mRS和年龄是出院不良结局的主要预测因素,术前血肿体积是再手术的唯一独立预测因素。低血肿负担患者中单独栓塞显示更早期功能稳定。

要点

  • 入院mRS是出院不良结局最强预测因素,阅片时应关注血肿占位效应与基线功能状态的关系
  • 术前血肿体积是再手术唯一独立预测因素,报告中应量化血肿体积
  • 低血肿负担(Q1-Q2)患者单独栓塞早期功能稳定性优于术前或术后栓塞策略

核心结论

  • 出院结局主要由入院mRS和年龄驱动,术前血肿体积与再手术风险相关
  • 低血肿负担(Q1-Q2)患者中单独栓塞较术前或术后策略显示更早期功能稳定

研究设计与样本

  • 回顾性队列研究,共135例接受脑膜中动脉栓塞的慢性硬膜下血肿患者
  • 仅纳入具有完整影像学数据的患者进行按术前血肿体积四分位分层分析
  • 按栓塞时机将全队列分为术前栓塞、术后栓塞和单独栓塞三组比较结局

关键影像表现/征象

  • 入院mRS分布在不同血肿体积四分位间存在差异(p=0.005),较大血肿体积组mRS≥3比例更高
  • 术后栓塞组严重程度模式较术前栓塞组更轻
  • 出院结局因栓塞时机不同而存在差异(p<0.001),单独栓塞组功能稳定性更高,尤其是在Q1组

诊断标准与关键数值

  • 入院mRS预测出院不良结局(mRS≥3)的比值比为6.209(p<0.001)
  • 年龄预测出院不良结局的比值比为1.078(p=0.027)
  • 术前血肿体积预测再手术的比值比为1.017(p=0.017)
  • 血肿体积四分位分层:以术前血肿体积将患者分为Q1至Q4四组,Q1血肿体积最小

临床应用与阅片要点

  • 报告慢性硬膜下血肿时应测量并记录血肿体积以便评估再手术风险
  • 关注入院功能状态与血肿体积的关系,较大血肿体积常伴随更高mRS
  • 低血肿负担患者可考虑单独脑膜中动脉栓塞作为替代手术的策略

局限性

  • 仅纳入具有完整影像学数据的患者,可能存在选择偏倚

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

BACKGROUND: Middle meningeal artery embolization (MMAE) has shown efficacy for chronic subdural hematoma (cSDH), but optimal patient selection and timing (pre-, post-surgical, or standalone) remain unclear. This study evaluated the impact of volume, and embolization timing on outcomes at discharge and follow-up.

METHODS: The study included 135 patients undergoing MMAE; only those with complete radiological data were analyzed. To reduce baseline clinical bias, patients were stratified into quartiles (Q) based on preoperative hematoma volume. Changes in functional status were assessed by calculating the difference in modified Rankin Scale (mRS) score between admission and discharge (ΔmRSa➝d), as well as between admission and follow-up (ΔmRSa➝f). The entire cohort was divided into three groups based on the timing of MMAE: pre-surgical, post-surgical and standalone.

RESULTS: At admission, mRS distribution differed across quartiles (p = 0.005), with better functional status more common in Q1 and higher mRS (≥ 3) increasing in larger volumes. At discharge, outcomes varied by embolization timing (p < 0.001). Stand-alone treatment was associated with greater clinical stability, especially in Q1, while improvement increased with hematoma volume in the pre-surgical group. The post-surgical group showed a milder pattern of severity compared to the pre-surgical group. The same trends were observed at follow-up. On multivariable analysis, admission mRS was the strongest predictor of poor outcome (mRS ≥ 3) (OR 6.209, p < 0.001), with age also significant (OR 1.078, p = 0.027). Preoperative hematoma volume was the only independent predictor of reoperation (OR 1.017, p = 0.017).

CONCLUSION: Discharge outcome was mainly driven by admission mRS and age, while preoperative hematoma volume was associated with reoperation risk. In patients with lower hematoma burden (Q1-Q2), stand-alone MMAE showed greater early functional stability than pre- or post-surgical strategies.

来源:Neuroradiology,查看原文。版权归原作者所有。

引用

  1. Palermo, Alexandre, D'Argento, et al. Middle meningeal artery embolization for chronic subdural hematoma: the role of timing and baseline hematoma volume. Neuroradiology. 2026. PMID: 42377421. doi:10.1007/s00234-026-04074-w

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。